Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients.
暂无分享,去创建一个
Claudio Pedone | Francesco Corica | C. Mussi | R. Antonelli Incalzi | C. Pedone | A. Corsonello | P. Carbonin | Andrea Corsonello | Chiara Mussi | Pierugo Carbonin | Raffaele Antonelli Incalzi | F. Corica
[1] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[2] W. Rocca,et al. Validation of the Hodkinson abbreviated mental test as a screening instrument for dementia in an Italian population. , 1992, Neuroepidemiology.
[3] S. Fukumoto,et al. Factors affecting progression of renal failure in patients with type 2 diabetes. , 2003, Diabetes care.
[4] Kdoqi Disclaimer. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[5] F. Follath,et al. Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. , 2000, British journal of clinical pharmacology.
[6] M. Pahor,et al. Pharmacosurveillance in hospitalized patients in Italy. Study design of the 'Gruppo Italiano di Farmacovigilanza nell'Anziano' (GIFA). , 1999, Pharmacological research.
[7] Roberto Bernabei,et al. Is Age an Independent Risk Factor of Adverse Drug Reactions in Hospitalized Medical Patients?* , 1991, Journal of the American Geriatrics Society.
[8] J L Bootman,et al. Drug-related morbidity and mortality. A cost-of-illness model. , 1995, Archives of internal medicine.
[9] D. Classen,et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. , 1997, JAMA.
[10] S. Mcphee,et al. Current Medical Diagnosis and Treatment , 2009, Journal of Nuclear Medicine.
[11] K. J. Lutz,et al. A cross-sectional study of muscle strength and mass in 45- to 78-yr-old men and women. , 1991, Journal of applied physiology.
[12] J. Erikssen,et al. Drug-related deaths in a department of internal medicine. , 2001, Archives of internal medicine.
[13] David W. Hosmer,et al. Applied Logistic Regression , 1991 .
[14] W. Stigelman,et al. Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .
[15] R. Bressler,et al. Principles of drug therapy for the elderly patient. , 2003, Mayo Clinic proceedings.
[16] J. Lea,et al. Diabetes mellitus and hypertension: key risk factors for kidney disease. , 2002, Journal of the National Medical Association.
[17] B. Astor,et al. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. , 2004, Kidney international.
[18] O Pelkonen,et al. Age and cytochrome P450‐linked drug metabolism in humans: An analysis of 226 subjects with equal histopathologic conditions , 1997, Clinical pharmacology and therapeutics.
[19] R. Lindeman,et al. Assessment of renal function in the old. Special considerations. , 1993, Clinics in laboratory medicine.
[20] D. Greenblatt,et al. A method for estimating the probability of adverse drug reactions , 1981, Clinical pharmacology and therapeutics.
[21] M. Sager,et al. Adverse drug events in hospitalized elderly. , 1998, The journals of gerontology. Series A, Biological sciences and medical sciences.
[22] Quan Dong Nguyen,et al. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. , 2003, JAMA.
[23] H. Beijer,et al. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies , 2002, Pharmacy World and Science.
[24] J. M. Guralnik,et al. Drug data coding and analysis in epidemiologic studies , 1994, European Journal of Epidemiology.
[25] M. Cesari,et al. Adverse Drug Reactions as Cause of Hospital Admissions: Results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA) , 2002, Journal of the American Geriatrics Society.
[26] K. Turnheim. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly , 2003, Experimental Gerontology.
[27] W. Ambrosius,et al. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity , 2003, Clinical pharmacology and therapeutics.
[28] Kay Brune,et al. Identification of Adverse Drug Reactions in Geriatric Inpatients Using a Computerised Drug Database , 2003, Drugs & aging.
[29] Ethan M Balk,et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[30] S. Knowles,et al. Gender Differences in Adverse Drug Reactions , 1998, Journal of clinical pharmacology.
[31] J. Schwartz. The Influence of Sex on Pharmacokinetics , 2003, Clinical pharmacokinetics.
[32] P. Corey,et al. Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .